Open access · CC-BY
via OpenAlex
Induced pluripotent stem cell-derived mesenchymal stem cells: whether they can become new stars of cell therapy
Zewen Wu, Yazhen Su, Jingxuan Li, Xinling Liu, Yang Liu, Li Zhao, Linxin Li, Liyun Zhang
Stem Cell Research & Therapy · 2024 · ▲ 32 citations
Abstract
Stem cell therapy constitutes a pivotal subject in contemporary discourse, with donor stem cells having been employed in research and clinical treatments for several decades. Primary cell transplantation encompasses diverse stem cell types, including ectomesenchymal stem cells, hematopoietic stem cells, and various stem cell derivatives such as vesicles and extracellular vesicles. Nevertheless, the emergence of cell engineering techniques has heralded a new epoch in stem cell therapy, markedly broadening their therapeutic potential. Induced pluripotent stem cells (iPSCs) epitomize a significant milestone in modern medical biology. This groundbreaking discovery offers significant potential in disciplines such as biology, pathophysiology, and cellular regenerative medicine. As a result, iPSCs derived differentiated cells have become a pioneering avenue for cell therapy research. Induced mesenchymal stem cells (iMSCs), derived from iPSCs, represent a novel frontier in MSCs related research. Empirical evidence suggests that iMSCs demonstrate enhanced proliferative capacities compared to natural MSCs, with diminished age-related variability and heterogeneity. Numerous clinical trials have highlighted the prospective superiority of iMSCs. This article synthesizes current basic research and clinical trials pertaining to iMSCs, aiming to provide a reference point for future research endeavors.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- OpenAlex
- DOI
- 10.1186/s13287-024-03968-x
- Canonical
- link ↗
- Fetched
- 2026-10-10 MST
Cite this
APA
Wu, Z., Su, Y., Li, J., Liu, X., Liu, Y., Zhao, L., Li, L., & Zhang, L. (2024). Induced pluripotent stem cell-derived mesenchymal stem cells: whether they can become new stars of cell therapy. <em>Stem Cell Research & Therapy</em>. https://doi.org/10.1186/s13287-024-03968-x
Vancouver
Wu Z, Su Y, Li J, Liu X, Liu Y, Zhao L, et al. Induced pluripotent stem cell-derived mesenchymal stem cells: whether they can become new stars of cell therapy. Stem Cell Research & Therapy. 2024. doi:10.1186/s13287-024-03968-x.
BibTeX
@article{zewen2024Induce,
title = {Induced pluripotent stem cell-derived mesenchymal stem cells: whether they can become new stars of cell therapy},
author = {Zewen Wu and Yazhen Su and Jingxuan Li and Xinling Liu and Yang Liu and Li Zhao and Linxin Li and Liyun Zhang},
journal = {Stem Cell Research & Therapy},
year = {2024},
doi = {10.1186/s13287-024-03968-x},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
IGI Global eBooks 2025
Citation only
Stem-Cell Therapy for Anti-Aging
Smart Medicine 2022
Open access · CC-BY
Reprogramming stem cells in regenerative medicine
Stem Cell Reviews and Reports 2020
Open access · OA
Mesenchymal Stem Cell Therapy for COVID-19: Present or Future
Hematology 2002
Preprint · OA
Stem Cells: Hype and Reality
Cells 2020
Open access · CC-BY
Role of Human Mesenchymal Stem Cells in Regenerative Therapy
Arthritis Research 2003
Open access · OA